Hide metadata

dc.date.accessioned2018-08-10T12:09:58Z
dc.date.available2018-09-22T22:31:23Z
dc.date.created2016-09-26T11:26:11Z
dc.date.issued2017
dc.identifier.citationBarrantes Bautista, Alejandro Wengenroth, Jonas Arnebrant, Thomas Haugen, Håvard Jostein . Poly-L-lysine/heparin multilayer coatings prevent blood protein adsorption. Journal of Colloid and Interface Science. 2017, 485, 288-295
dc.identifier.urihttp://hdl.handle.net/10852/62853
dc.description.abstractThe adsorption of blood proteins, serum albumin (BSA), immunoglobulin G (IgG) and fibrinogen (FGN), onto model SiO2 planar surfaces coated with poly-l-lysine/heparin multilayers (PLL/HEP) has been investigated by means of ellipsometry and quartz crystal microbalance with dissipation. Aiming at the development of low fouling coatings, this study has been focused on the effects that the number of layers and the type of polyelectrolyte present on the topmost layer have on the adsorption of these proteins. The three proteins interact with PLL-ended coatings whereas HEP-ended coatings prevent the adsorption of both BSA and IgG and induce a decrease in the adsorbed amount of FGN, down to 0.4 mg/m2 for three bilayers, as the number of PLL/HEP bilayers increases. These results suggest that heparin-ended multilayers prevent protein adsorption, which is an indicative of good blood compatibility. As a consequence we propose that PLL/HEP coatings could be used for the development of vascular medical devices.en_US
dc.languageEN
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titlePoly-L-lysine/heparin multilayer coatings prevent blood protein adsorptionen_US
dc.typeJournal articleen_US
dc.creator.authorBarrantes Bautista, Alejandro
dc.creator.authorWengenroth, Jonas
dc.creator.authorArnebrant, Thomas
dc.creator.authorHaugen, Håvard Jostein
cristin.unitcode185,16,17,62
cristin.unitnameBiomaterialer
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1385457
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Colloid and Interface Science&rft.volume=485&rft.spage=288&rft.date=2017
dc.identifier.jtitleJournal of Colloid and Interface Science
dc.identifier.volume485
dc.identifier.startpage288
dc.identifier.endpage295
dc.identifier.doihttp://dx.doi.org/10.1016/j.jcis.2016.09.046
dc.identifier.urnURN:NBN:no-65414
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn0021-9797
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/62853/2/Manuscript_PLL-HEP-BloodProteins-Cristin.pdf
dc.type.versionAcceptedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International